Remdesivir Entèmedyè CAS 1911578-98-7 2-Ethylbutil ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate
Manifakti Komèsyal Pwovizyon pou Remdesivir ak entèmedyè ki gen rapò ak kalite siperyè
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilil Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutil ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir metabolit (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Entèmedyè CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo [2,1-f][1,2,4] triazin-4-amine CAS 937046-98-5
Pyrrolo [1,2-F][1,2,4] Triazin-4-Amine CAS 159326-68-8
4-Amino-7-yodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Non Chimik | 2-Etilbutil ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate |
Sinonim | N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester;Remdesivir Entèmedyè;Remdesivir-001;Remdesivir enpurte 21 |
Nimewo CAS | 1911578-98-7 |
Nimewo CAT | RF-PI303 |
Estati Stock | Nan stock, pwodiksyon echèl jiska dè santèn de kilogram |
Fòmil molekilè | C21H27N2O7P |
Pwa molekilè | 495.38 |
Dansite | 1.2g/cm3 |
Pwen k ap fonn | 92.0 ~ 96.0 ℃ (lit.) |
Pwen bouyi | 356.7 ℃ nan 760 mmHg |
Kondisyon Shipping | Anba tanperati anbyen |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Poud blan pou blan |
Enfrawouj Spectrum | Konfòm ak estrikti |
Pite | ≥99.0% |
Pèt sou siye | ≤0.50% |
Single enpurte | ≤0.50% |
Enpurte total | ≤1.0% |
Metal lou | ≤20ppm |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Remdesivir (CAS 1809249-37-3) |
Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite ak ensèk nuizib.
2-Ethylbutil ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate (CAS 1911578-98-7) se yon entèmedyè kle avanse nan preparasyon analòg ki gen rapò ak Remdesivir.Remdesivir se yon prodrog monofosforamidat nan yon analòg adenozin, se yon ajan ankèt antiviral ki gen gwo spectre ak aktivite in vitro kont coronavirus SARS, coronavirus MERS ak, pi resamman, Covid-19.Remdesivir te devlope sitou kòm yon tretman pou enfeksyon filoviris tankou maladi viris Ebola oswa viris Marburg.Answit, yo te jwenn Remdesivir pou montre aktivite antiviral kont lòt viris RNA yon sèl-bloke tankou viris respiratwa syncytial, viris Nipah, viris Hendra, viris Junin, viris lafyèv Lassa ak coronavirus yo (ki gen ladan viris MERS ak SARS).Dènyèman, li ap etidye kòm yon medikaman pwomèt pou tretman COVID-19 (nouvo viris kalite SARS).Remdesivir, devlope pa Gilead Sciences, se yon prodrog adenozin ki metabolize nan fòm aktif li GS-441524 ki entèfere ak aksyon viral RNA-depandan RNA polymerase ak evade koreksyon pa viral exoribonuclease (ExoN), sa ki lakòz yon diminisyon nan pwodiksyon RNA viral.